SCHEMBL3978684

SCHEMBL3978684

NC(=O)c1cccc(CNc2nccc(Nc3cc(CCc4cccc(O)c4)n[nH]3)n2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.48
MAP4K4 O95819 1/20 0.48
PIM1 P11309 1/20 0.48
GSK3B P49841 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
IGF1R P08069 5/20 0.43
FGFR1 P11362 5/20 0.43
KDR P35968 5/20 0.43
MAPK8 P45983 2/20 0.39
PAK4 O96013 2/20 0.39
CHEK1 O14757 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CDK2 P24941 1/20 0.39
MAPK1 P28482 1/20 0.39
AKT1 P31749 1/20 0.39
PLK1 P53350 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
MAP2K1 Q02750 1/20 0.39
STAT6 P42226 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3981643 0.89 IGF1R (0.50) CLK4IGF1RFGFR1KDRCDK2
SCHEMBL3979516 0.86 IGF1R (0.57) IGF1RFGFR1KDRCDK2AURKA
SCHEMBL3979717 0.83 IGF1R (0.47) CLK4IGF1RFGFR1KDR
SCHEMBL4026982 0.82 IGF1R (0.55) CDC7MAP4K4PIM1GSK3BCLK4
SCHEMBL3926678 0.80 IGF1R (0.50) CDC7MAP4K4PIM1GSK3BCLK4
SCHEMBL4010199 0.80 IGF1R (0.49) CDC7MAP4K4PIM1GSK3BCLK4
SCHEMBL5110454 0.79 IGF1R (0.64) CDC7MAP4K4PIM1GSK3BCLK4
SCHEMBL5096885 0.78 IGF1R (0.62) CDC7MAP4K4PIM1GSK3BCLK4
SCHEMBL4018302 0.77 IGF1R (0.59) CDC7MAP4K4PIM1GSK3BCLK4
SCHEMBL4010070 0.77 IGF1R (0.49) CDC7MAP4K4PIM1GSK3BCLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009056886-A1 PYRIMIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF FGFR ACTIVITY ASTRAZENECA AB (SE) 2009-05-07 WO disclosed